<DOC>
	<DOCNO>NCT02884518</DOCNO>
	<brief_summary>The purpose study determine whether dopamine synthesis capacity use [ 18 fluorine ( F ) ] -DOPA PET patient schizophrenia maintenance phase predict treatment discontinuation .</brief_summary>
	<brief_title>Predicting Antipsychotic Discontinuation Psychosis</brief_title>
	<detailed_description>There two group : healthy control group ( n=12 ) patient group ( n=26 ) . The patient group recruit subject diagnose first episode psychosis occur within 2 year treat antipsychotic 1 year . Participants complete clinical scale undergo PET scan . Subjects patient group receive reduce intake antipsychotic 25 % week four-week period also undergo PET image baseline , 7 week , 8 week mark detect correlation capacity presynaptic dopamine relapse patient discontinue treatment .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>1 . Patient group 1 . Patients meet DSMIV criterion schizophrenia , schizoaffective disorder , schizophreniform disorder 2. patient diagnose first episode psychosis occur within 2 year treat antipsychotic least 1 year . 3 . Patients maintain stable state 3 month without medication change baseline . 2 . Healthy control group Healthy control Axis I disorder report past event neurological psychiatric illness assess Structured Clinical Interview DSM Disorders 1 . Participants neurological illness head trauma , seizure meningitis . 2 . Participants diagnose Mental retardation ( IQ &lt; 70 ) 3 . Participants severe personality disorder , substance abuse dependence ( except nicotine abuse dependence ) severe medical condition .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>dopamine receptor occupancy</keyword>
	<keyword>antipsychotic</keyword>
	<keyword>positron emission tomography</keyword>
</DOC>